Sandra Panem

Provides research and policy solutions

Develops bioinformatics software

Functions as a College/University

Cross Atlantic focuses only on US-based healthcare opportunities, especially in drug discovery, devices and services. They place emphasis on oncology, neurological diseases and infectious diseases. They look for companies seeking to develop more effective, less expensive products or services which reduce the need for surgery or hospitalization and provide higher quality care at a lower cost. Cross Atlantic invests in companies beyond the start-up stage. They seek companies whose innovative products show clear competitive advantages. Such products should be based on proprietary technology or specialized service expertise and should meet significant market needs. In-depth review of patent portfolios is a standard part of their due diligence. The firm expects at least a 3X return of capital with an average holding period of 4 years. Exit strategies may include the sale of securities through IPOs, secondary public and private offerings, sales in connection with strategic alliance/corporate partnering transactions or merger and acquisition transactions.

Operates as a biotechnology tools company that manufactures and markets echo liquid handling systems

Operates as a clinical-stage biopharmaceutical company which develops and commercializes cell transplantation products

Vector Asset Management invests in later-stage private and public companies in the life sciences and healthcare industries. Specific areas of interest include: biotechnology, pharmaceuticals, medical devices, diagnostics, plant and animal sciences, healthcare services, healthcare information technology and consumer applications of emerging healthcare technologies. They focus on companies that are raising capital in the private markets prior to the point at which they can access the public markets or execute an alternative exit strategy. Vector looks for companies ready to move from development stage to commercially viable operating entities in a relatively short time. The firm also participates in equity transactions involving securities of small- to mid-cap public companies in the life sciences and healthcare area. Most of Vector's investments are negotiated directly with company management. Vector is an active investor and generally leads or co-leads their investments. They usually serve on the Board of Directors of their portfolio companies. Investments range from $5 million to $15 million with an investment horizon of one to three years.

Provides healthcare shopping and navigation tool services

Operates as a venture capital fund